tiprankstipranks
Trending News
More News >
CBIZ (CBZ)
NYSE:CBZ
Advertisement

CBIZ (CBZ) AI Stock Analysis

Compare
183 Followers

Top Page

CBZ

CBIZ

(NYSE:CBZ)

Rating:72Outperform
Price Target:
$68.00
▲(9.03% Upside)
CBIZ's strong financial performance and positive earnings call sentiment are the primary drivers of its score. Despite technical indicators suggesting bearish momentum, the company's strategic growth initiatives, particularly the Marcum acquisition, bolster its outlook. Valuation concerns due to a high P/E ratio are offset by robust operational performance.
Positive Factors
Cost Management
Strong cost control measures led to meaningful upside to the model on adjusted EBITDA margin and adjusted EPS.
Growth Strategy
Management remains confident in supplementing organic growth with acquisitions, contributing significantly to the company's growth strategy.
Revenue Growth
Clients are showing healthy levels of optimism due to easing labor and supply chain pressures.
Negative Factors
Economic Environment
The uncertainty around tariffs, geopolitical unrest, and government funding cuts contributed to lower price realization in core accounting services.
Revenue Guidance
Shares traded lower primarily due to lighter-than-expected full-year revenue guidance.
Revenue Realization
Realized rate increases of 4% year-to-date are roughly 200-300 basis points lower than management’s expectations, representing a roughly $75 million headwind to full-year revenue.

CBIZ (CBZ) vs. SPDR S&P 500 ETF (SPY)

CBIZ Business Overview & Revenue Model

Company DescriptionCBIZ, Inc. provides financial, insurance, and advisory services in the United States and Canada. The company operates through three segments: Financial Services, Benefits and Insurance Services, and National Practices. The Financial Services segment offers accounting and tax, financial advisory, valuation, risk and advisory, and government healthcare consulting services. The Benefits and Insurance Services provides employee benefits consulting, payroll/human capital management, property and casualty insurance, and retirement and investment services. The National Practices segment offers information technology managed networking and hardware, and health care consulting services. It primarily serves small and medium-sized businesses, as well as individuals, governmental entities, and not-for-profit enterprises. The company was incorporated in 1987 and is headquartered in Cleveland, Ohio.
How the Company Makes MoneyCBIZ generates revenue primarily through its service offerings, which include accounting services, tax preparation, employee benefits consulting, and risk management solutions. The company's revenue model is built on a fee-for-service basis, where clients pay for the specific services rendered. Key revenue streams include consulting fees from advisory services, commissions from insurance products, and recurring revenue from ongoing client relationships in payroll and employee benefits. Additionally, CBIZ has established strategic partnerships with various organizations to enhance its service offerings, which further contributes to its earnings through expanded market reach and client acquisition.

CBIZ Earnings Call Summary

Earnings Call Date:Jul 30, 2025
(Q2-2025)
|
% Change Since: -18.10%|
Next Earnings Date:Oct 23, 2025
Earnings Call Sentiment Neutral
The earnings call reflects a company that is experiencing strong revenue and EBITDA growth primarily due to the Marcum acquisition, while also facing challenges in nonrecurring revenue and pricing pressures. The overall performance is buoyed by strategic decisions and successful integrations, although market uncertainties pose ongoing challenges.
Q2-2025 Updates
Positive Updates
Strong Revenue Growth
Second quarter revenue was $684 million, and first half revenue was $1.5 billion, representing a 63% and 66% increase, respectively, largely driven by the Marcum acquisition.
Significant EBITDA Improvement
Adjusted EBITDA increased by 128% or $66 million for the quarter and more than doubled to $356 million in the first half, with an adjusted EBITDA margin of 17% in the quarter and 23% year-to-date.
Marcum Acquisition Synergies
The Marcum acquisition is considered one of the most important strategic decisions, providing opportunities for accelerated growth and profitability. Early integration results are positive.
Benefits and Insurance Segment Growth
The B&I segment delivered revenue of $102 million in the second quarter, up nearly $5 million or approximately 5% compared to last year, with a 21% increase in adjusted EBITDA.
Successful Workforce Integration
Enhanced team utilization and improved compensation expenses were achieved with nearly 450 fewer full-time equivalent employees in core businesses compared to last year.
Negative Updates
Market Conditions Impacting Nonrecurring Revenue
Overall revenue for nonrecurring project-based portions of the business, excluding SEC-related practice, is down low single digits year-over-year due to economic uncertainties.
Pressure on Rate Increases
Year-to-date rate increases averaged about 4%, which is 200 to 300 basis points below expectations, creating a headwind of about $75 million for the full year.
Higher Interest and Tax Expenses
Second quarter interest expense was higher by $22 million compared to last year, and tax expense was $7 million higher due to increased pretax income.
SEC Practice Decline
The SEC-related business, including SPAC-related revenue, has seen declines, and the current market-dependent attributes present challenges.
Company Guidance
During the CBIZ Second Quarter 2025 Results Conference Call, management provided guidance suggesting that the revenue for the year is expected to be at the low end of their previously forecasted range of $2.8 billion to $2.95 billion. The call highlighted that year-to-date organic revenue growth for core services within the Benefits and Insurance segment and core accounting and tax services was in low single digits, while the National Practice segment grew by 13%. Adjusted EBITDA for the first half of the year more than doubled compared to the previous year, reflecting the strength of the business model and the impact of the Marcum acquisition. However, the rate increases averaged about 4%, which is 200 to 300 basis points below expectations, creating a headwind of approximately $75 million for the full year. Furthermore, CBIZ's results included a 63% increase in second-quarter revenue, reaching $684 million, and a 66% increase in first-half revenue to $1.5 billion. Adjusted EBITDA margins improved by nearly 500 basis points to 23% year-to-date, with adjusted diluted earnings per share increasing by 64% to $0.95 in the second quarter. CBIZ also noted a targeted deleveraging plan to reach 2.5x leverage by the end of 2026, highlighting their confidence in generating meaningful free cash flow to invest and achieve this target.

CBIZ Financial Statement Overview

Summary
CBIZ demonstrates strong financial health with solid revenue growth and efficient operational margins. Improvements in leverage and a strong balance sheet are positives, though fluctuations in net income and free cash flow growth present some risk.
Income Statement
82
Very Positive
CBIZ has shown a strong revenue growth trajectory with the TTM revenue increasing significantly from the previous annual period. The gross profit margin is healthy, and the net profit margin has improved over the periods, indicating efficient cost management. The EBIT and EBITDA margins are also robust, showing good operational efficiency. However, the net income fluctuates, which could be a potential risk.
Balance Sheet
75
Positive
The company's debt-to-equity ratio has improved in the TTM, indicating better leverage management. The return on equity is strong, reflecting efficient use of shareholder capital. The equity ratio indicates a healthy balance between equity and total assets. However, the high total liabilities could pose risks if not managed properly.
Cash Flow
78
Positive
CBIZ's operating cash flow is consistently positive and covers net income effectively. There is a positive free cash flow, which is crucial for future investments. However, the free cash flow growth rate shows some volatility, and investing activities have seen significant cash outflows, which might be a concern if it continues.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.42B1.81B1.59B1.41B1.10B963.90M
Gross Profit327.02M182.47M225.10M223.37M159.29M138.55M
EBITDA312.99M144.76M226.99M211.14M122.83M115.62M
Net Income109.08M41.04M120.97M105.35M70.89M78.30M
Balance Sheet
Total Assets4.54B4.47B2.04B1.88B1.63B1.51B
Cash, Cash Equivalents and Short-Term Investments39.82M13.83M8.09M4.70M2.00M4.65M
Total Debt1.96B1.83B551.01M474.47M331.25M279.69M
Total Liabilities2.65B2.69B1.25B1.17B923.39M811.13M
Stockholders Equity1.89B1.78B791.62M713.45M704.55M595.30M
Cash Flow
Free Cash Flow105.07M110.78M130.46M117.49M122.17M135.27M
Operating Cash Flow124.13M123.69M153.51M126.13M131.15M146.84M
Investing Cash Flow-1.11B-1.13B-79.39M-99.12M-82.01M-46.41M
Financing Cash Flow1.01B1.04B-77.11M-17.34M-69.00M-76.61M

CBIZ Technical Analysis

Technical Analysis Sentiment
Negative
Last Price62.37
Price Trends
50DMA
70.09
Negative
100DMA
71.67
Negative
200DMA
75.75
Negative
Market Momentum
MACD
-2.73
Positive
RSI
37.52
Neutral
STOCH
52.84
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CBZ, the sentiment is Negative. The current price of 62.37 is below the 20-day moving average (MA) of 67.74, below the 50-day MA of 70.09, and below the 200-day MA of 75.75, indicating a bearish trend. The MACD of -2.73 indicates Positive momentum. The RSI at 37.52 is Neutral, neither overbought nor oversold. The STOCH value of 52.84 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CBZ.

CBIZ Risk Analysis

CBIZ disclosed 28 risk factors in its most recent earnings report. CBIZ reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

CBIZ Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$4.76B15.5717.61%1.42%3.40%13.75%
72
Outperform
$3.38B35.977.84%46.49%-25.62%
71
Outperform
$3.12B21.467.15%0.79%4.18%18.93%
69
Neutral
$3.01B38.744.30%2.12%3.52%-67.27%
65
Neutral
$2.67B15.3615.18%3.45%-0.30%27.34%
58
Neutral
$45.94M10.92
52
Neutral
$2.93B549.40-13.57%65.34%-633.72%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CBZ
CBIZ
62.37
-7.92
-11.27%
ABM
ABM Industries
48.14
-5.36
-10.02%
MMS
Maximus
84.40
-3.34
-3.81%
UNF
UniFirst
173.63
-11.50
-6.21%
FA
First Advantage
16.48
-1.56
-8.65%
YSXT
YSX Tech Co., Ltd Class A
1.93
-2.10
-52.11%

CBIZ Corporate Events

Executive/Board ChangesShareholder Meetings
CBIZ Holds Annual Stockholders Meeting, Key Decisions Made
Neutral
May 16, 2025

On May 15, 2025, CBIZ, Inc. held its annual stockholders meeting where key decisions were made, including the election of directors and the ratification of KPMG LLP as the independent accounting firm for the year ending December 31, 2025. Additionally, stockholders approved the compensation of the company’s Named Executive Officers, reflecting continued support for the current leadership and strategic direction.

The most recent analyst rating on (CBZ) stock is a Buy with a $86.00 price target. To see the full list of analyst forecasts on CBIZ stock, see the CBZ Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 01, 2025